Ditchcarbon
  • Customers
  1. Organizations
  2. Biomerieux
Public Profile
Pharmaceutical Preparation Manufacturing
FR
updated 10 days ago

Biomerieux

Company website

bioMérieux, a global leader in in vitro diagnostics, is headquartered in France and operates extensively across Europe, North America, and Asia. Founded in 1963, the company has consistently innovated in the fields of microbiology and molecular biology, achieving significant milestones such as the development of the first automated microbiology system. Specialising in diagnostic solutions for infectious diseases, bioMérieux offers a range of unique products, including rapid tests and automated systems that enhance laboratory efficiency and accuracy. Their commitment to quality and innovation has solidified their position as a trusted partner in healthcare, with notable achievements in improving patient outcomes through timely diagnostics. With a strong focus on research and development, bioMérieux continues to lead the way in advancing diagnostic technologies worldwide.

DitchCarbon Score

How does Biomerieux's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

79

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

Biomerieux's score of 79 is higher than 89% of the industry. This can give you a sense of how well the company is doing compared to its peers.

89%

Let us know if this data was useful to you

Biomerieux's reported carbon emissions

In 2024, bioMérieux reported total greenhouse gas emissions of approximately 1,127,000,000 kg CO2e, with emissions distributed across various scopes: 22,000,000 kg CO2e (Scope 1), 34,000,000 kg CO2e (Scope 2, market-based), and 1,127,000,000 kg CO2e (Scope 3). The company has set ambitious targets to reduce its emissions, committing to a 63% reduction in absolute Scope 1 and 2 emissions by 2034, using 2019 as the baseline year. Additionally, bioMérieux aims for 67% of its suppliers, by emissions, to have science-based targets by 2026. In 2023, bioMérieux's emissions in the UK were reported as 6,400,000 kg CO2e (Scope 3), with Scope 1 and 2 emissions at 380,000 kg CO2e and 90,000 kg CO2e, respectively. The company has also disclosed its emissions data for previous years, showing a consistent commitment to transparency and accountability in its climate strategy. The reduction initiatives include a near-term target of a 50% reduction in Scope 1 and 2 emissions by 2030, compared to 2019 levels. These targets are aligned with the Science Based Targets initiative (SBTi) and reflect bioMérieux's commitment to addressing climate change within the healthcare equipment and supplies sector. The emissions data and reduction targets are cascaded from the parent company, bioMérieux S.A., ensuring a unified approach to sustainability across the corporate family.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2018201920202021202220232024
Scope 1
31,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
Scope 2
-
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
Scope 3
241,000,000
000,000,000
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Biomerieux's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Biomerieux is in FR, which has a very low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Biomerieux is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Charles River Laboratories

US
•
Research and development services (73)
Updated 3 days ago

Sgs

CH
•
Other services (93)
Updated 2 days ago

Bio Rad

US
•
Research and development services (73)
Updated 4 days ago

Agilent

US
•
Other services (93)
Updated about 4 hours ago

Siemens Medical Solutions Diagnostics, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Diasorin

IT
•
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250807.8
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy